CHATEAL AX Trademark Application - Oral Contraceptives
Summary
The USPTO has received a trademark application for 'CHATEAL AX' for use in connection with oral contraceptives. The application was filed on November 12, 2025, under the 'intent to use' provision.
What changed
The United States Patent and Trademark Office (USPTO) has recorded a new trademark application for the mark 'CHATEAL AX'. This application, filed under the 'intent to use' provision, specifically designates its use for oral contraceptives.
This filing represents the initial step in the trademark registration process. While this is not a final registration, it signals a company's intent to use the mark in commerce for the specified pharmaceutical product. Compliance officers should note this filing as an indicator of potential market activity and intellectual property claims within the pharmaceutical sector.
Archived snapshot
Mar 24, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
← USPTO Trademark Applications
CHATEAL AX
Intent to Use TM99492399 Kind: intenttouse Mar 22, 2026
Abstract
Oral contraceptives
Filing Date
2025-11-12
Related changes
Get daily alerts for USPTO Trademarks - Pharmaceuticals (Class 005)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Trademarks - Pharmaceuticals (Class 005) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.